ARINDAM CHAUDHURI’S 4 REASONS WHY YOU SHOULD CHOOSE IIPM...
Pfizer
Inc. will now bring out a new class of oral HIV medicines after the much awaited approval from the US regulators. The drug Selzentry is the first of its kind to keep the HIV virus that causes AIDS from getting inside healthy immune cells, the ones that came before the attacking virus! It’s also known as Maraviroc, which helps block the CCR5 co-receptor serving as the main entry for the HIV virus into immune cells. This drug can be used in patients who have used other medicines and for those for whom a test has made it sure that their HIV strain is associated to the CCR5 receptor. Precisely about 50% to 60% of all patients who have been treated with other AIDS drugs meet that definition. With the advent of this new drug, life expectancy for an HIV carrier patient is expected to rise further.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2007
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
For More IIPM Info, Visit Below....
IIPM Economy Review
IIPM :- Cicero's Challenge is going global
The Indian Institute of Planning and Management (I...
After CDMA, will nokia miss the 3G bus ?
Time for Awards at IIPM
STUDENTS AGAINST CORRUPTION & KICKBACKS : SACK
HRIC :- Human Resource Intelligence Cell
Heavy dut(t)y stress Sanjay Dutt Bollywood Actor
The Business of B-School Rankings & The Big Farce
36TH Full Time Programme In Planning & Entrepreneu...
Pfizer
Inc. will now bring out a new class of oral HIV medicines after the much awaited approval from the US regulators. The drug Selzentry is the first of its kind to keep the HIV virus that causes AIDS from getting inside healthy immune cells, the ones that came before the attacking virus! It’s also known as Maraviroc, which helps block the CCR5 co-receptor serving as the main entry for the HIV virus into immune cells. This drug can be used in patients who have used other medicines and for those for whom a test has made it sure that their HIV strain is associated to the CCR5 receptor. Precisely about 50% to 60% of all patients who have been treated with other AIDS drugs meet that definition. With the advent of this new drug, life expectancy for an HIV carrier patient is expected to rise further.For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2007
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
For More IIPM Info, Visit Below....
IIPM Economy Review
IIPM :- Cicero's Challenge is going global
The Indian Institute of Planning and Management (I...
After CDMA, will nokia miss the 3G bus ?
Time for Awards at IIPM
STUDENTS AGAINST CORRUPTION & KICKBACKS : SACK
HRIC :- Human Resource Intelligence Cell
Heavy dut(t)y stress Sanjay Dutt Bollywood Actor
The Business of B-School Rankings & The Big Farce
36TH Full Time Programme In Planning & Entrepreneu...
No comments:
Post a Comment